ALXA Related Analyst Ratings

Apr 3, 2013 09:04 AM Piper Jaffray Upgrades Alexza Pharma (ALXA) to Overweight

Jan 3, 2013 04:56 PM Piper Jaffray Starts Alexza Pharma (ALXA) at Neutral

Dec 4, 2012 08:07 AM Roth Capital Starts Alexza Pharma (ALXA) at Buy

Aug 10, 2012 10:38 AM JMP Securities Reiterates Market Outperform, $12 Target on Alexza Pharma (ALXA) After Q2

Oct 4, 2011 08:06 AM JMP Securities Upgrades Alexza Pharma (ALXA) to Market Outperform

Oct 12, 2010 09:10 AM JMP Securities Downgrades Alexza Pharmaceuticals (ALXA) to Market Perform

Oct 11, 2010 04:43 PM RBC Cuts Alexza Pharma (ALXA) to Sector Perform, Slashes Price Target to $1.50

Oct 11, 2010 12:14 PM Piper Jaffray Cuts Alexza Pharma (ALXA) to Neutral in Mid-Day Note

Feb 11, 2010 09:21 AM WBB Securities Upgrades Alexza Pharmaceuticals (ALXA) to Strong Buy

Mar 10, 2009 11:28 AM Wedbush Morgan Initiates Coverage on Alexza Pharmaceuticals (ALXA) with a Buy

Mar 18, 2008 08:02 AM JMP Securities Upgrades Alexza Pharmaceuticals (ALXA) to Outperform

Apr 18, 2006 12:37 PM Piper Jaffray Starts Alexza Pharma (ALXA) at Outperform

Apr 17, 2006 08:59 AM RBC Capital Initiates Coverage on Alexza Pharmaceuticals (ALXA) With an Outperform